top of page

Lxbio at Business Year Portugal 2023

TP-102 compassionate uses cases presented at ECCMID 2023

Signing of a PRR Partnership Agreement with the Portuguese Government

Explorer Investements

New Biopharmaceutical

facility and new RYD site

bottom of page